EcoDrugPlus

Voltage-Dependent Calcium Channel Gamma-7 Subunit

Ensembl ID : ENSOKIG00005015585
Gene Symbol: LOC109904455
3 Cross references
180 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSOKIG00005040196
Gene Symbol: LOC109906901
3 Cross references
179 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1-Like

Ensembl ID : ENSOKIG00005029137
Gene Symbol: LOC109879081
3 Cross references
216 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-4-Like

Ensembl ID : ENSOKIG00005040813
Gene Symbol: LOC109876625
2 Cross references
162 Possible Orthologues:

Wee1-Like Protein Kinase 1-A

Ensembl ID : ENSOKIG00005015485
Gene Symbol: LOC109897719
3 Cross references
199 Possible Orthologues:

Wee1-Like Protein Kinase 1-B

Ensembl ID : ENSOKIG00005039016
Gene Symbol: LOC109867809
3 Cross references
199 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSOKIG00005004002
Gene Symbol: XDH
1 Cross references
210 Possible Orthologues:

Ensembl ID : ENSOKIG00005009445
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSOKIG00005026169
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOKIG00005010709
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOKIG00005007224
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSOKIG00005006935
Gene Symbol: -
Cross references: -
240 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).